Literature DB >> 1487958

Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice.

A Demoz1, N Willumsen, R K Berge.   

Abstract

The effect of oral administration of purified (95%) eicosapentaenoic acid on serum lipids, hepatic peroxisomal enzymes, antioxidant enzymes and lipid peroxidation was compared with that of palmitic acid fed mice and corresponding controls. After 10 d, a dose of 1000 mg eicosapentaenoic acid per day/kg body weight lowered serum triglycerides by 45%, while no significant change in serum cholesterol level was noted in comparison to palmitic acid fed mice and controls. Hepatic acyl-CoA oxidase and catalase activities increased by 50% and 30%, respectively, in the eicosapentaenoic acid fed group. In addition, the hepatic reduced glutathione content and the activities of glutathione transferase, glutathione peroxidase and glutathione reductase, increased significantly during eicosapentaenoic acid treatment. The levels of hepatic lipid peroxides were lower after eicosapentaenoic acid feeding, while no significant change was noted in the palmitic acid fed mice when compared to the controls. Taken together, the present data demonstrate for the first time that at hypolipidemic doses eicosapentaenoic acid feeding i) enhances the hepatic antioxidant defense, and ii) does not cause a significant differential induction of the two peroxisomal enzymes, acyl-CoA oxidase and catalase, as was noted after administration of hypolipidemic peroxisome proliferating compounds, such as clofibrate in rodents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487958     DOI: 10.1007/bf02535573

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

2.  Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.

Authors:  J K Reddy; D L Azarnoff; C E Hignite
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

3.  Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.

Authors:  J K Reddy; N D Lalwani; M K Reddy; S A Qureshi
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

4.  The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.

Authors:  D E Moody; J K Reddy
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

Review 5.  Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

Authors:  S H Goodnight; W S Harris; W E Connor; D R Illingworth
Journal:  Arteriosclerosis       Date:  1982 Mar-Apr

6.  Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.

Authors:  R K Berge; O M Bakke
Journal:  Biochem Pharmacol       Date:  1981-08-15       Impact factor: 5.858

7.  Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.

Authors:  S A Beck; K L Smith; M J Tisdale
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

Review 8.  Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

Authors:  J K Reddy; N D Lalwai
Journal:  Crit Rev Toxicol       Date:  1983       Impact factor: 5.635

9.  Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography.

Authors:  A M Svardal; M A Mansoor; P M Ueland
Journal:  Anal Biochem       Date:  1990-02-01       Impact factor: 3.365

10.  Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis.

Authors:  B S Reddy; C Burill; J Rigotty
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

View more
  13 in total

1.  Peroxisomes in mice fed a diet supplemented with low doses of fish oil.

Authors:  C Van den Branden; D De Craemer; M Pauwels; J Vamecq
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

2.  Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans.

Authors:  G S Rambjør; A I Wålen; S L Windsor; W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 3.  Antioxidants in exercise nutrition.

Authors:  C K Sen
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.

Authors:  L Frøyland; H Vaagenes; D K Asiedu; A Garras; O Lie; R K Berge
Journal:  Lipids       Date:  1996-02       Impact factor: 1.880

5.  Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids.

Authors:  J B Hansen; R K Berge; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

6.  Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats.

Authors:  Satoshi Kajikawa; Tsuyoshi Harada; Akiko Kawashima; Kazunori Imada; Kiyoshi Mizuguchi
Journal:  Dig Dis Sci       Date:  2009-10-24       Impact factor: 3.199

7.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

8.  Dietary fatty acids, membrane transport, and oxidative sensitivity in human erythrocytes.

Authors:  D E Mills; M Murthy; W R Galey
Journal:  Lipids       Date:  1995-07       Impact factor: 1.880

9.  N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury.

Authors:  Jessica Zúñiga; Milena Cancino; Fernando Medina; Patricia Varela; Romina Vargas; Gladys Tapia; Luis A Videla; Virginia Fernández
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

10.  N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis.

Authors:  Rodrigo Valenzuela; Alejandra Espinosa; Daniel González-Mañán; Amanda D'Espessailles; Virginia Fernández; Luis A Videla; Gladys Tapia
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.